| Completed | 18F-LY3950321-01 Biodistribution and Safety Study Diagnostic Agent Adverse Reaction, Radiation Exposure | EARLY_Phase 1 | 2023-02-28 |
| Unknown | Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging Neoplasms, Neoplasms Malignant | EARLY_Phase 1 | 2022-04-12 |
| Completed | Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's Disease Alzheimer Disease | Phase 3 | 2019-03-28 |
| Completed | A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan Alzheimer Disease | Phase 3 | 2019-03-26 |
| Completed | Tau Screening Study in Subjects With Early Symptomatic AD Alzheimer Disease | Phase 2 | 2018-03-08 |
| Completed | Tau Screening Study in Patients With Early Symptomatic AD Alzheimer Disease | Phase 2 | 2017-11-21 |
| Completed | Flortaucipir PET Imaging in Subjects With FTD Frontotemporal Dementia | Phase 1 | 2017-04-11 |
| Terminated | Flortaucipir 18F PET Imaging in BIOCARD Study Cognitive Decline | Phase 1 | 2017-03-23 |
| Completed | 18F-AV-1451 High Resolution Autopsy Study Alzheimer's Disease | Phase 1 | 2016-11-26 |
| Completed | Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials Alzheimer Disease, Cognition Disorders | — | 2016-10-01 |
| Completed | Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05 Alzheimer's Disease | Phase 2 | 2016-08-01 |
| Withdrawn | 18F-AV-1451 PET Imaging in TBI Traumatic Brain Injury | Phase 1 | 2015-10-01 |
| Completed | 18F-AV-1451 Autopsy Study Alzheimer's Disease | Phase 3 | 2015-09-01 |
| Completed | Tau Imaging in Professional Fighters Alzheimer's Disease | Phase 1 | 2015-02-18 |
| Completed | Augmenting Flortaucipir Dosimetry Estimates Alzheimer's Disease | Phase 1 | 2015-01-01 |
| Completed | Clinical Evaluation of Flortaucipir F 18 Alzheimer's Disease, Traumatic Brain Injury, Depression | Phase 2 | 2014-12-01 |
| Completed | Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's Disease Alzheimer Disease, Mild Cognitive Impairment | Phase 1 | 2014-10-01 |
| Withdrawn | Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians Alzheimer's Disease | N/A | 2014-10-01 |
| Completed | Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers Progressive Supranuclear Palsy, Corticobasal Degeneration | Phase 1 | 2014-08-12 |
| Completed | 18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Tr Chronic Traumatic Encephalopathy | Phase 2 | 2014-06-01 |
| Terminated | Imaging Characteristics of a Follow-up 18F-AV-1451 Scan Alzheimer's Disease | Phase 2 | 2014-05-01 |
| Completed | Florbetapir Calibration to the Centiloid Scale Alzheimer's Disease | Phase 1 | 2014-04-01 |
| Completed | Evaluation of Reader Training Processes Alzheimer's Disease | Phase 4 | 2014-03-01 |
| Completed | The Feasibility of Florbetapir Quantitation in Europe Alzheimer's Disease | Phase 4 | 2014-03-01 |
| Completed | Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects Alzheimer's Disease | Phase 2 / Phase 3 | 2013-12-01 |
| Completed | A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired Subjects Alzheimer's Disease | Phase 1 | 2013-11-13 |
| Completed | Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired Subjects Alzheimer Disease | EARLY_Phase 1 | 2013-08-16 |
| Completed | The Feasibility of Florbetapir Quantitation Alzheimers Disease | Phase 4 | 2013-08-01 |
| Completed | Quantitative 18F-AV-133 PET Imaging in Subjects With Diabetes and Healthy Controls Type 2 Diabetes | Phase 1 | 2012-12-01 |
| Completed | A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteer Alzheimer's Disease, Mild Cognitive Impairment | Phase 2 / Phase 3 | 2012-10-01 |
| Completed | Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Sca Alzheimer's Disease | Phase 4 | 2012-10-01 |
| Completed | A Study of Florbetapir (18F) in Japanese Healthy Volunteers Alzheimer's Disease | Phase 1 | 2012-08-01 |
| Terminated | A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808 Alzheimers Disease | EARLY_Phase 1 | 2012-07-01 |
| Terminated | A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807 Alzheimers Disease, AD | EARLY_Phase 1 | 2012-07-01 |
| Completed | A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Di Parkinson's Disease, Primary Parkinsonism, Lewy Body Parkinson's Disease | Phase 2 / Phase 3 | 2012-04-01 |
| Completed | Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans Alzheimer Disease, Mild Cognitive Impairment, Neurodegenerative Diseases | N/A | 2011-08-01 |
| Completed | Potential of Florbetapir F 18 PET to Inform Clinical Diagnosis and Management of Patients With Progressive Cog Progressive Cognitive Decline | Phase 3 | 2011-07-01 |
| Completed | Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognit Alzheimer's Disease | Phase 3 | 2011-02-01 |
| Completed | Evaluation of Physician Training Methods to Read Florbetapir-PET Scans Alzheimer's Disease | N/A | 2011-01-01 |
| Terminated | A Trial of 18F-AV-133 Positron Emission Tomography (PET) Type 1 Diabetes, Type 2 Diabetes | Phase 1 | 2010-06-01 |
| Completed | Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07 Alzheimer's Disease | Phase 3 | 2010-03-01 |
| Completed | A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET) Dementia With Lewy Bodies, Alzheimer's Disease, Parkinson's Disease | Phase 1 / Phase 2 | 2010-03-01 |
| Completed | Evaluation of PET Scan Timing Relative to AV-45 Injection Time Alzheimer's Disease | N/A | 2010-03-01 |
| Completed | Clinical Evaluation of Florbetapir F 18 (18F-AV-45) Alzheimer Disease, Mild Cognitive Impairment, Neurodegenerative Diseases | Phase 2 | 2009-12-01 |
| Completed | Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and N Alzheimer's Disease, Frontotemporal Dementia | Phase 2 | 2009-09-01 |
| Completed | Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal Individu Alzheimer's Disease | Phase 2 | 2009-03-01 |
| Completed | Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir Alzheimer's Disease, Mild Cognitive Impairment | Phase 2 | 2009-01-01 |
| Completed | Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease Patients Parkinson's Disease | Phase 2 | 2009-01-01 |
| Completed | Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain Alzheimer's Disease | Phase 3 | 2008-12-01 |
| Completed | A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Alzheimer's Disease, Mild Cognitive Impairment | Phase 2 | 2008-06-01 |
| Completed | A Study of 18F-AV-45 in Alzheimer's Disease (AD) and Healthy Volunteers Alzheimer's Disease | Phase 1 | 2008-04-01 |
| Completed | A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers Alzheimer Disease | Phase 1 | 2008-03-01 |
| Completed | A Study of 18F-AV-45 in Healthy Volunteers Alzheimer Disease | Phase 1 | 2007-10-01 |
| Completed | A Preliminary Study of 18F-AV-45 in Alzheimer's Disease and Healthy Elderly Volunteers Alzheimer Disease | EARLY_Phase 1 | 2007-06-01 |